# PROFIT - Prostate Fractionated Irradiation Trial

> **NCT00304759** · PHASE3 · COMPLETED · sponsor: **Ontario Clinical Oncology Group (OCOG)** · enrollment: 1204 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** 7800 cGy/39 fractions in 8 weeks
- **PROCEDURE:** 6000 cGy/20 fractions in 4 weeks

## Key facts

- **NCT ID:** NCT00304759
- **Lead sponsor:** Ontario Clinical Oncology Group (OCOG)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2017-07-15
- **Final completion:** 2017-07-15
- **Target enrollment:** 1204 (ESTIMATED)
- **Last updated:** 2017-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304759, "PROFIT - Prostate Fractionated Irradiation Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00304759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*